Mr. Thompson, diagnosed with advanced prostate cancer with bone metastases, reports increased pelvic pain. As his nurse, what is the most appropriate initial intervention to manage his pain while considering his overall treatment plan?

C) Coordinate with the healthcare team to initiate opioid therapy for pain management.

A) Administer acetaminophen regularly to manage his pain.

B) Suggest he uses heat therapy on the affected areas to relieve pain.

C) Coordinate with the healthcare team to initiate opioid therapy for pain management.

D) Encourage increased physical activity to enhance pain tolerance.

Mr. Thompson has been diagnosed with advanced prostate cancer with bone metastases. As his nurse, which of the following actions is most appropriate to prioritize in his care plan to address his current condition?

C) Coordinate with the healthcare provider to start bisphosphonate therapy to reduce the risk of skeletal-related events.

A) Initiate a high-calcium diet to strengthen Mr. Thompson’s bones and prevent fractures.

B) Educate Mr. Thompson on the importance of regular exercise to manage his weight and improve mobility.

C) Coordinate with the healthcare provider to start bisphosphonate therapy to reduce the risk of skeletal-related events.

D) Encourage Mr. Thompson to increase his fluid intake to manage potential chemotherapy side effects.

Mr. Thompson, who is undergoing androgen deprivation therapy (ADT), presents with increased fatigue, weakness, worsening pelvic pain, and new-onset hypertension. His lab results show anemia and slightly elevated serum calcium levels. Which of the following nursing interventions is most appropriate to address his current symptoms and prevent further complications?

C) Discuss with the healthcare provider the initiation of bisphosphonate therapy and the addition of a low-dose corticosteroid.

A) Encourage increased dietary calcium to strengthen bones.

B) Educate Mr. Thompson about the importance of limiting fluid intake to manage hypertension.

C) Discuss with the healthcare provider the initiation of bisphosphonate therapy and the addition of a low-dose corticosteroid.

D) Suggest Mr. Thompson engage in vigorous exercise to combat fatigue.

Mr. Thompson is experiencing increased fatigue, weakness, and worsening pelvic pain two weeks after starting androgen deprivation therapy (ADT). Considering his current symptoms and laboratory findings, which nursing intervention is the priority to address his immediate health concerns?

B) Initiate a fall risk assessment and implement safety precautions due to anemia and weakness.

A) Educate Mr. Thompson on the importance of hydration to manage elevated calcium levels.

B) Initiate a fall risk assessment and implement safety precautions due to anemia and weakness.

C) Encourage increased protein intake to address the weight loss and prevent muscle wasting.

D) Schedule a follow-up appointment with the dietitian to manage elevated blood glucose levels.

Mr. Thompson, who is undergoing bisphosphonate therapy, presents with new symptoms of nausea and occasional vomiting, and his blood glucose levels have risen significantly. Which nursing intervention should be prioritized to address the immediate concerns related to his current condition?

A) Administer antiemetic medication as prescribed to manage nausea and vomiting.

B) Consult with the healthcare provider to adjust the diabetes medication regimen.

C) Increase oral hydration to address potential dehydration and support renal function.

D) Schedule a consultation with the dietitian to modify Mr. Thompson's diet to support his nutritional needs.

Mr. Thompson is experiencing gastrointestinal side effects from his bisphosphonate therapy, as well as poorly controlled blood glucose levels. Which nursing intervention would be most appropriate to address these issues concurrently?

B) Encourage Mr. Thompson to take bisphosphonates with a full glass of water and remain upright for 30 minutes, while collaborating with the healthcare provider to adjust his diabetes medication.

A) Educate Mr. Thompson on taking bisphosphonates with food to reduce nausea and monitor his blood glucose levels daily.

B) Encourage Mr. Thompson to take bisphosphonates with a full glass of water and remain upright for 30 minutes, while collaborating with the healthcare provider to adjust his diabetes medication.

C) Suggest taking bisphosphonates at bedtime to minimize gastrointestinal discomfort and decrease his dietary carbohydrate intake.

D) Advise Mr. Thompson to take an antacid 30 minutes before bisphosphonates and schedule regular insulin therapy without consulting the healthcare provider.

Based on Mr. Thompson's current clinical presentation and laboratory findings, which nursing intervention should be prioritized to address his immediate respiratory compromise?

B) Initiate oxygen therapy to improve oxygen saturation levels.

A) Administer a blood transfusion to improve oxygen-carrying capacity.

B) Initiate oxygen therapy to improve oxygen saturation levels.

C) Administer prescribed diuretics to reduce pleural effusion.

D) Encourage increased fluid intake to address potential dehydration.

Mr. Thompson is showing signs of mild bilateral lower extremity edema and intermittent palpitations after receiving a diuretic therapy and blood transfusion. What is the most appropriate nursing intervention to address his current symptoms?

C) Elevate Mr. Thompson's legs when sitting to reduce edema and monitor cardiac status.

A) Increase the dosage of the diuretic to further reduce fluid retention.

B) Encourage Mr. Thompson to increase his fluid intake to manage diuretic side effects.

C) Elevate Mr. Thompson's legs when sitting to reduce edema and monitor cardiac status.

D) Administer a beta-blocker to manage palpitations and heart rate.

Mr. Thompson, a patient with prostate cancer, is being monitored after receiving diuretic therapy and a blood transfusion. He now presents with mild bilateral lower extremity edema and intermittent palpitations. What is the most appropriate nursing intervention to address these new symptoms?

A) Increase the frequency of vital signs monitoring to every 2 hours.

B) Administer an additional dose of diuretic to reduce edema.

C) Educate the patient to limit fluid intake to 1 liter per day.

D) Prepare the patient for an immediate echocardiogram.

prostate cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Prostate cancer primarily originates from genetic mutations in prostate cells, leading to uncontrolled cell proliferation. Androgen receptors play a crucial role, as they bind to testosterone and dihydrotestosterone, stimulating abnormal cell growth.

• Secondary mechanism: The overexpression of growth factors, such as insulin-like growth factor (IGF), further enhances tumor growth by promoting angiogenesis, which supplies nutrients and oxygen to the growing tumor mass.

• Key complication: As the tumor progresses, it can invade nearby tissues and metastasize to bones and lymph nodes, causing pain, fractures, and potentially life-threatening systemic symptoms.

Patient Profile

Demographics:

65 years old, male, retired engineer

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Benign Prostatic Hyperplasia

• Current medications: Metformin, Lisinopril, Tamsulosin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing difficulty urinating and pelvic pain

• Key symptoms: Frequent urination, nocturia, hematuria, weight loss, fatigue

• Vital signs: Blood Pressure 150/95 mmHg, Heart Rate 95 bpm, Respiratory Rate 20 breaths/min, Temperature 99.1°F

Section 1

Following the initial presentation, Mr. Thompson underwent further diagnostic evaluations to better understand the progression of his condition. A prostate-specific antigen (PSA) test revealed elevated levels at 45 ng/mL, significantly higher than the normal range, suggesting advanced prostate cancer. Additionally, a digital rectal exam confirmed an irregular, nodular prostate, raising concerns about potential local invasion. An MRI of the pelvis showed a large heterogeneous mass in the prostate, with signs of extracapsular extension and potential involvement of the seminal vesicles. Bone scan results were concerning for metastatic spread, revealing increased uptake in the lumbar spine and pelvis, consistent with bone metastases.

These findings indicate a shift in Mr. Thompson’s status, signifying that the cancer has progressed beyond the prostate to other areas, necessitating a more aggressive treatment approach. The presence of bone metastases correlates with his reported pelvic pain and weight loss, which suggests systemic involvement. Clinically, this necessitates consideration of both oncologic treatments, such as androgen deprivation therapy (ADT) or chemotherapy, and supportive measures to address bone health, such as bisphosphonates or denosumab, to prevent further skeletal complications.

The healthcare team must now prioritize managing Mr. Thompson's symptoms while initiating systemic therapy to control the cancer’s progression. Monitoring his blood pressure and managing his comorbidities, such as hypertension and diabetes, remain crucial to prevent additional complications. The next steps will involve discussing treatment options with Mr. Thompson and considering his preferences and quality of life, while also preparing for possible side effects and the need for multidisciplinary support to address the complex challenges associated with advanced prostate cancer.

Section 2

Two weeks into the commencement of androgen deprivation therapy (ADT), Mr. Thompson presents to the clinic with new-onset symptoms that require careful evaluation. He reports increased fatigue, weakness, and worsening pelvic pain, which are causing significant discomfort and impacting his daily activities. On physical examination, his vital signs reveal a blood pressure of 160/95 mmHg, a pulse rate of 85 beats per minute, and a weight loss of 4 kilograms since the last visit. His blood glucose levels are slightly elevated, indicating the need for closer monitoring given his diabetic condition.

Laboratory tests reveal an alarming drop in hemoglobin levels to 10.5 g/dL, suggesting the development of anemia, which could be a consequence of both cancer progression and the ADT. Additionally, his serum calcium levels are slightly elevated at 10.8 mg/dL, prompting concerns about potential hypercalcemia, a known complication in patients with bone metastases. These findings suggest a need to reassess his current treatment plan, particularly focusing on managing the bone metastases more aggressively to alleviate symptoms and prevent further complications.

Given these developments, the healthcare team is prompted to discuss with Mr. Thompson the possibility of initiating bisphosphonate therapy to address the bone health issues and mitigate the risk of fracture and hypercalcemia. They also consider the potential benefits of adding a low-dose corticosteroid to manage the pain and fatigue, while closely monitoring its impact on his diabetes and hypertension. This juncture in Mr. Thompson's care highlights the importance of an integrated approach, combining oncologic and supportive therapies, to optimize his quality of life and manage the multifaceted challenges presented by his advanced cancer.

Section 3

As Mr. Thompson begins bisphosphonate therapy to address the bone health concerns, the healthcare team remains vigilant in monitoring for both therapeutic effects and potential side effects. Within a week, Mr. Thompson reports a notable reduction in pelvic pain, allowing him to resume some daily activities with less discomfort. However, during a follow-up visit, he presents with new symptoms of nausea and occasional vomiting, raising concerns about gastrointestinal tolerance to the bisphosphonates. His vital signs reveal a slight improvement in blood pressure at 150/90 mmHg, but his pulse rate has increased to 95 beats per minute, potentially indicating an underlying stress response or dehydration.

Laboratory results show a further decline in hemoglobin levels to 9.8 g/dL, exacerbating the anemia and suggesting that additional supportive measures may be necessary. His serum calcium levels have stabilized at 10.5 mg/dL, indicating a positive response to the bisphosphonate treatment. However, his blood glucose levels have risen to concerning levels, with fasting glucose at 180 mg/dL, necessitating a reassessment of his diabetic management plan, especially in light of the potential addition of corticosteroids.

The healthcare team faces the challenge of balancing Mr. Thompson's complex needs, including adjusting his diabetes medication regimen to account for the potential hyperglycemic effects of corticosteroids while addressing his anemia and ensuring adequate hydration and nutritional support. This situation underscores the need for continuous monitoring and adaptation of his care plan, emphasizing an interdisciplinary approach to manage the intertwined aspects of his advanced cancer, comorbid conditions, and treatment-related side effects. The next step involves a collaborative discussion with Mr. Thompson and his family to review the current interventions, address any concerns, and reinforce the importance of ongoing communication and follow-up in optimizing his clinical outcomes.

Section 4

As the healthcare team continues to monitor Mr. Thompson's condition, they observe a noticeable change in his patient status. Over the course of a few days, Mr. Thompson begins to experience increasing fatigue and shortness of breath, which become more pronounced with minimal exertion. His family reports that he has been sleeping longer hours and appears more lethargic than usual, raising concerns about his overall energy levels and oxygenation status. On examination, Mr. Thompson's respiratory rate has increased to 22 breaths per minute, and auscultation reveals diminished breath sounds in the lower lobes bilaterally, suggesting the possibility of atelectasis or fluid accumulation.

The healthcare team decides to conduct a chest X-ray to investigate these respiratory symptoms further. The imaging reveals mild pleural effusions and early signs of pulmonary congestion, which could be contributing to his dyspnea. Concurrently, his laboratory results indicate a worsening anemia, with hemoglobin now at 9.2 g/dL, and a slight elevation in serum creatinine at 1.4 mg/dL, pointing to potential renal involvement or dehydration. These developments necessitate prompt intervention to address his respiratory compromise, manage fluid balance, and consider strategies to improve his hemoglobin levels.

In light of these new complications, the team convenes to reassess Mr. Thompson's care plan, emphasizing the importance of a multidisciplinary approach. They consider the introduction of diuretics to manage the pleural effusions while carefully monitoring his renal function. Additionally, the possibility of a blood transfusion is discussed to alleviate his anemia-related fatigue and improve his oxygen-carrying capacity. This evolving situation highlights the critical nature of ongoing assessment and adaptation in managing Mr. Thompson's complex clinical picture, ensuring that each intervention is tailored to his dynamic needs and aimed at optimizing his quality of life amidst the challenges of advanced prostate cancer and its treatment.

Section 5

As the healthcare team implements the initial interventions, they closely monitor Mr. Thompson's response to the treatment plan. Within 24 hours of administering a diuretic, there is a noticeable improvement in his respiratory status. Mr. Thompson reports a slight reduction in shortness of breath, and his respiratory rate decreases to 18 breaths per minute. However, auscultation still reveals diminished breath sounds in the lower lobes, suggesting that while the pleural effusions may have reduced slightly, they have not completely resolved. The team decides to continue with the diuretic therapy while ensuring regular monitoring of his renal function, given the initial elevation in serum creatinine. Repeat labs show a stable creatinine level at 1.4 mg/dL, indicating that his renal function remains adequate despite the diuretic use.

To address Mr. Thompson's anemia and related fatigue, the team proceeds with a blood transfusion, administering one unit of packed red blood cells. Following the transfusion, Mr. Thompson's hemoglobin level rises to 10.4 g/dL, and he reports feeling marginally more energetic, though still inclined to rest for extended periods. His oxygen saturation shows a subtle improvement to 94% on room air, reflecting a better oxygen-carrying capacity. However, his heart rate remains elevated at 102 beats per minute, warranting further observation for any signs of transfusion-related complications or cardiac strain.

Despite these interventions, Mr. Thompson begins to exhibit new signs of discomfort, specifically reporting mild bilateral lower extremity edema and intermittent palpitations. This development prompts the team to consider the impact of fluid shifts and potential cardiac involvement, possibly exacerbated by his underlying prostate cancer and associated treatments. A cardiology consultation is requested to evaluate his cardiac status, and an echocardiogram is planned to rule out heart failure or other cardiovascular complications. The team's comprehensive approach underscores the importance of continuous assessment and adaptation to emerging clinical findings, ensuring that Mr. Thompson's care remains both proactive and responsive to his evolving needs.